After significant criticism, the Obama administration recently dropped a new Medicare Part B drug-pricing plan. This plan would have caused Medicare to reduce payments for Medicare Part B prescriptions, which are those given to patients… Read More
Lyon and Indianapolis, May 31, 2016 – Adocia (Euronext Paris: ADOC) and Eli Lilly and Company (NYSE: LLY) announced today positive topline results from a Phase 1 clinical trial evaluating BioChaperone Lispro, an ultra-rapid formulation
Although this may not relate to diabetes medications or products for you, we thought you might be interested in seeing this:
… Read More
May 16, 2016, Los Angeles, CA – It’s an age-old crime: stealing. But it’s not about picking a pocket or
FRIDAY, April 15, 2016 (HealthDay News) — Metformin, a commonly prescribed diabetes drug, may reduce the risk of dying from some cancers for postmenopausal women with type 2 diabetes, a new study suggests.
The study found that for women… Read More
In late September 2015, the FDA finally approved Tresiba, a diabetes drug from Novo Nordisk. This once daily medication is a long-acting drug that was previously rejected in 2013 after the FDA requested more data about the heart risks … Read More